# Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions

> **NCT00833521** · PHASE1 · COMPLETED · sponsor: **Teva Pharmaceuticals USA** · enrollment: 38 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Zolpidem 10 mg tablets
- **DRUG:** AMBIEN® 10 mg tablets

## Key facts

- **NCT ID:** NCT00833521
- **Lead sponsor:** Teva Pharmaceuticals USA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-02
- **Primary completion:** 2002-02
- **Final completion:** 2002-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00833521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00833521, "Zolpidem Tartrate 10 mg Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00833521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*